Back to Results
First PageMeta Content
Stem cells / Emerging technologies / Biotechnology / Cell biology / Cell therapy / Regenerative medicine / Clinical trial / Ischemia / Myocardial infarction / Biology / Medicine / Health


Media Contact: Carissa Matton Bioheart, Inc[removed]NW 4th Street, Suite 212 Sunrise, Florida[removed]Phone: [removed]removed]
Add to Reading List

Document Date: 2014-11-24 21:00:06

Open Document

File Size: 164,31 KB

Share Result on Facebook

City

Indianapolis / Sunrise / /

Company

Aspen CO. / Bioheart Inc. / Physical Medicine/Rehab Associates / Facebook / Carissa Matton Bioheart Inc. / /

/

Event

FDA Phase / Product Issues / /

Facility

Aspen Institute / /

IndustryTerm

cell technology industry delivering cell therapies / biotechnology / clinical site / /

MedicalCondition

scar / degenerative disc disease / congestive heart failure / peripheral vascular disease / cmatton@bioheartinc.com For Immediate Release BIOHEART ANNOUNCES EXPANSION OF CLINICAL STUDY FOR DEGENERATIVE DISC DISEASE / acute myocardial infarctions / chronic heart ischemia / chronic and acute heart damage / heart failure / /

MedicalTreatment

cell therapy / /

Organization

Institutional Review Board / International Cellular Medicine Society / Securities and Exchange Commission / ICMS IRB / Aspen Institute for Antiaging & Regenerative Medicine / /

Person

Robert Silbert / Julian Robert Gershon Jr. / /

/

Position

principal investigator / /

Product

MyoCell / tissue / DEGENERATIVE DISC DISEASE / /

ProgrammingLanguage

FL / /

ProvinceOrState

Indiana / Florida / /

Technology

cell therapy / biotechnology / stem cells / Regenerative Medicine / /

URL

www.bioheartinc.com / /

SocialTag